Sassine Ghanem
About Sassine Ghanem
Sassine Ghanem is an Associate Editor for Malignant Hematology and a Stem Cell Transplant and Cellular Therapy Fellow at The University of Texas MD Anderson Cancer Center. He has a robust background in hematology and oncology, having held various positions in medical institutions across the United States, including roles at Staten Island University Hospital and SUNY Downstate Medical Center.
Current Role at theMednet
Sassine Ghanem serves as the Associate Editor for Malignant Hematology at theMednet. In this role, he engages in editorial work that focuses on the dissemination of knowledge within the specialized field of malignant hematology. His contributions help ensure that the medical community has access to the latest research and developments in this area.
Experience at MD Anderson Cancer Center
Currently, Sassine Ghanem is a Stem Cell Transplant and Cellular Therapy Fellow at The University of Texas MD Anderson Cancer Center. He has held this position since 2021, focusing on advanced treatment modalities within hematology and oncology. His work at this prestigious institution underscores his commitment to clinical excellence and patient care.
Previous Positions in Hematology
Before his current role, Sassine Ghanem worked as a Chief Hematology Oncology Fellow at SUNY Downstate Medical Center from 2020 to 2021. He also completed a Hematology/Medical Oncology Fellowship at the same institution from 2018 to 2021. His extensive training in these roles has equipped him with a strong foundation in hematology and oncology.
Educational Background
Sassine Ghanem obtained his Doctor of Medicine (M.D.) degree from Saint Joseph University of Beirut, where he studied from 2006 to 2013. His educational journey began at Saint Joseph School - Cornet Chehwan, where he completed his high school education. This academic background laid the groundwork for his medical career.
Clinical Research Expertise
Sassine Ghanem has a strong background in clinical research, particularly in the field of malignant hematology. His research efforts contribute to the advancement of knowledge and treatment options in this area, reflecting his dedication to improving patient outcomes through evidence-based practices.